Verastem (VSTM) 2025 Earnings Outlook for Investors
As Verastem prepares for its 2025 earnings outlook, investors should focus on cash runway, collaboration milestones, ...
Stock picking may pay off in certain market conditions and for investors with time and expertise. Learn factors to consider before deviating from index funds.
26,454 articlesAs Verastem prepares for its 2025 earnings outlook, investors should focus on cash runway, collaboration milestones, ...
Nine months after Jim Cramer touted Energy Transfer as a top dividend pick for retirees, the stock has delivered on i...
As June begins, NVIDIA has surged to the top of investor lists as the biggest June bet on AI infrastructure, backed b...
Vertex’s $10 billion cash bid for Crinetics sparked a sharp rally, lifting the stock nearly to the offer price as tra...
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
Altria sits around $73 with a near-6% yield, yet a from 52-week low: glaring risk and consumer softness raise questio...
As UnitedHealth gears up for its July 16 results, traders focus on pricing power and rising cash flow as the main rea...
Hims & Hers Health shares surged in premarket trading after reports they ended a dispute with Novo Nordisk by forging...
As investors eye Regal Rexnord’s Q1 2026 earnings, the focus turns to demand momentum, margin discipline, and capital...
Crypto exchanges are expanding into US stocks and tokenized equities, launching a two-front challenge to traditional ...
Jim Cramer argues that the MAG 7 must be analyzed separately, not as a single basket, outlining five core reasons eac...